Pulmonary versus systemic delivery of levofloxacin. The isolated lung of the rat as experimental approach for assessing pulmonary inhalation

Pulmonary Pharmacology and Therapeutics

Volumn 21, Issue 2, 2008, Pages 298-303

  Jesús Valle, María José de ^a   González López, Francisco ^a   Sánchez Navarro, Amparo ^a  

^a UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

Isolated rat lung; Levofloxacin; Pulmonary delivery; Pulmonary drug disposition; Respiratory patterns

Indexed keywords

LEVOFLOXACIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DISPOSITION; DRUG DISTRIBUTION; DRUG TISSUE LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ISOLATED LUNG; LUNG FLUID; LUNG INFECTION; MALE; NONHUMAN; PARTITION COEFFICIENT; PRIORITY JOURNAL; RAT; TIDAL VOLUME;

ADMINISTRATION, INHALATION; ANIMALS; ANTI-BACTERIAL AGENTS; BODY FLUIDS; BRONCHOALVEOLAR LAVAGE FLUID; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; LUNG; MALE; OFLOXACIN; PULMONARY ALVEOLI; RATS; RATS, WISTAR; TISSUE DISTRIBUTION;

EID: 40049110469     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2007.07.003     Document Type: Article

References (18)

1. Paladino J.A., and Callen W.A. Fluoroquinolone benchmarking in relation to pharmacokinetic and pharmacodynamic parameters. J Antimicrob Chemother 51 Suppl. S1 (2003) 43-47
2. Hooper D.C. Clinical applications of quinolones. Biochim Biophys Acta 1400 (1998) 45-61
3. Ferrara A.M. New fluoroquinolones in lower respiratory tract infections and emerging patterns of pneumococcal resistance. Infection 33 (2005) 106-114
4. Zhanel G.G., Ennis K., Vercaigne L., Walkty A., Gin A.S., Embil J., et al. A critical review of the fluoroquinolones. Focus on respiratory tract infections. Drugs 62 1 (2002) 13-59
5. Furlanut M., Brollo L., Lugatti E., Di Qual E., Dolcet F., Talmassons G., et al. Pharmacokinetic aspects of levofloxacin 500 mg once daily during sequential intravenous/oral therapy in patients with lower respiratory tract infections. J Antimicrob Chemother 51 (2003) 101-106
6. Conte Jr. J.E., Golden J.A., McIver M., and Zurlinden E. Intrapulmonary pharmacokinetics and pharmacodynamics of high-dose levofloxacin in healthy volunteer subjects. Int J Antimicrob Agents 28 (2006) 114-121
7. Rodvold K.A., Danziger L.H., and Gotfried M.H. Steady-state plasma and bronchopulmonary concentrations of intravenous levofloxacin and azithromycin in healthy adults. Antimicrob Agents Chemother 47 8 (2003) 2450-2457
8. Gotfried M.H., Danziger L.H., and Rodvold K.A. Steady-state plasma and intrapulmonary concentrations of levofloxacin and ciprofloxacin in healthy adult subjects. Chest 119 (2001) 1114-1122
9. Bertino J., and Fish D. The safety profile of the fluoroquinolones. Clin Ther 22 7 (2000) 798-817
10. Ball P. Adverse drug reactions: implications for the development of fluoroquinoles. J Antimicrob Chemother 51 Suppl. S1 (2003) 21-27
11. Perea J.R.A., Díaz de Rada B.S., and Quetglas E.G. Revista Española de Quimioterapia 13 3 (2000)
12. Sakagami M. In vivo, in vitro and ex vivo models to assess pulmonary absorption and disposition of inhaled therapeutics for systemic delivery. Adv Drug Deliv Rev 58 (2006) 1030-1060
13. Martinez M.S.M., Gandarillas C.I.C., Lanao J.M., and Sánchez Navarro A. Influence of flow rat on the disposition of levofloxacin and netilmicin in the isolated rat lung. Eur J Pharm Sci 24 (2005) 325-332
14. Yamaoka K., Nakagawa T., and Uno T. Statistical moments in pharmacokinetics. J Pharmacokinet Biopharm 6 (1978) 547-558
15. Weiss M. Distribution kinetics in the body and single organs: moment analysis. In: DÁrgenio D.Z. (Ed). Advanced methods of pharmacokinetics and pharmacodynamic system analysis (1995), Plenum, New York, NY 89-100
16. Kruskal W.H., and Wallis W.A. Use of ranks in one-criterion variance analysis. J Am Stat Assoc 47 260 (1952) 583-621
17. Lee L.J., Sha X., Gotfried M.H., Howard J.R., Dix R.K., and Fish D.N. Penetration of levofloxacin into lung tissue after oral administration to subjects undergoing lung biopsy or lobectomy. Pharmacotherapy 18 (1998) 35-41
18. Von Baum H., Böttcher S., Hoffmann H., and Sonntag H.G. Tissue penetration of a single dose of levofloxacin intravenously for antibiotic prophylaxis in lung surgery. J Antimicrob Chemother 47 (2001) 719-730